Long Non-Coding RNA Landscape in Prostate Cancer Molecular Subtypes: A Feature Selection Approach

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Prostate cancer exhibits significant molecular genomic heterogeneity.
• Current clinical practice does not fully utilize molecular subtypes for patient stratification.
• Long non-coding RNAs (lncRNAs) represent a potential avenue for improved classification.

Purpose of the Study:

• To identify robust long non-coding RNAs (lncRNAs) for enhanced prostate cancer patient stratification.
• To discover novel lncRNA biomarkers for predicting prognosis and treatment response.
• To explore the utility of bioinformatic approaches in uncovering cancer biology.

Main Methods:

• Utilized a feature selection bioinformatic approach on The Cancer Genome Atlas (TCGA) dataset.
• Analyzed lncRNA expression patterns to identify prognostic and predictive biomarkers.
• Performed co-expression analysis to link lncRNAs with potentially druggable pathways.

Main Results:

• Identified LINC00668 and lnc-SAYSD1-1 as positive prognostic biomarkers in ERG-positive prostate cancer patients.
• Discovered LINC00920 lncRNA overexpression is associated with better hormone therapy outcomes.
• Found lnc-ZMAT3-3 overexpression linked to low-grade prostate cancer and identified three lncRNAs correlated with druggable pathways.

Conclusions:

• Data mining and bioinformatic analyses of public datasets can reveal crucial insights into prostate cancer biology.
• Selected lncRNAs demonstrate potential for refining patient stratification and guiding therapeutic decisions.
• This research highlights the importance of lncRNAs in understanding prostate cancer heterogeneity and developing targeted therapies.